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Flurofamide (N-[diaminophosphinyl]-4-fluorobenzamide), a urease inhibitor, was a potent
inhibitor of the growth of Ureaplasma urealyticum. As little as 10 ttM flurofamide (2Ag/ml)
prevented any growth, but U. urealyticum survived for about eight hours before colony counts
become undetectable. Flurofamide was a specific inhibitor of U. urealyticum since it did not
inhibit growth of fourMycoplasma species orAcholeplasma hippikon. Flurofamide was 1,000
times more active than acetohydroxamic acid and thus has promise as a chemotherapeutic
agent and a biochemical tool.
Urease is perhaps the most interesting protein currently, among the multitudinous
proteins occurring in the organisms of the Mycoplasmatales. The enzyme and its
substrate urea appear critical to Ureaplasma urealyticum because both the growth
rate and the growth yield of the organisms in culture are functions of the urea con-
centration in the medium. The maximum growth rate is achieved at about 3 mM
urea and the yield is directly related to the urea concentration up to 32 mM, pro-
vided that adequate buffering capacity is maintained [1]. Growth does not occur in
the absence of urea. Compounds such as allantoin (and its derivatives) which appear
to support growth [2], apparently do so because they spontaneously break down to
urea [Kenny: unpublished data]. The apparent function of urease activity is to pro-
mote ATP synthesis by a possible chemiosmotic mechanism. Romano et al. [3] have
shown that ATP synthesis is dependent upon the presence of urea and an active
ATPase. ATP synthesis was blocked by the urease inhibitor, acetohydroxamic acid,
indicating that urease was indispensable to ATP synthesis. The urea requirement of
U. urealyticum is further remarkable in that no other organism is known to require
urea in a rich medium: urea is required only by bacteria which possess urease, when
it is the sole nitrogen source in defined media.
The enzyme appears to be atypical urease. The Km is about 5 mM urea and V,nax is
26 mM urea with an optimum pH for activity in the 5.0-6.5 range [4,5]. The enzyme
appears to be a major antigen of the species and the eight human serotypes studied
all share the same serological specificity, which is distinct from that of jack-bean
urease [Sayed, Kenny: in press]. The molecular weight ofthe active form obtained in
SDS polyacrylamide gel electrophoresis is 140,000 daltons; upon boiling, an inactive
band at 70,000 daltons appears [Sayed, Kenny: in press]. Several isoenzymes appear
to exist [4,6].
"Flurofamide" is a new inhibitor of bacterial urease(s) designed to inhibit urease
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All rights of reproduction in any form reserved.enzymes within intact cells [7]. In the present study, I report the inhibition ofgrowth
of U. urealyticum by small concentrations of flurofamide. This paper is a pre-
liminary report of recent data, which I believe may have possible chemotherapeutic
and biological significance.
MATERIALS AND METHODS
Inhibitors
Both "flurofamide" (N-[diaminophosphinyl]-4-fluorobenzamide coded EU-4534,
lot 6692-037A) and acetohydroxamic acid (coded EU-2350, lot 2883-A-90A) were
gifts ofNorwich-Eaton Pharmaceuticals (Norwich, NY). The structural formulae of
flurofamide [7] and acetohydroxamic acid are shown in Fig. 1. Both compounds
were soluble in water, and stock solutions were sterilized by filtration.
Organisms
U. urealyticum types 1,2,4, and 8 were obtained from J. Robertson; types 3 and 5
were ATCC (American Type Culture Collection) strains 27815 and 27817, respec-
tively. Mycoplasma species were selected as representative of the seroclusters of
mycoplasma species [8] and included: Mycoplasma hominis (ATCC 23114),
Mycoplasma gallisepticum (ATCC 15302), Mycoplasma species bovine group 7 (N
29B), and Mycoplasmafelis (B2). Acholeplasma hippikon (ATCC 29725) was used
as a representative of genus Acholeplasma. Proteus vulgaris (ATCC 13315) was the
only bacterial species tested.
Cultivation ofOrganisms and Sensitivity Testing
Growth curves of U. urealyticum were conducted as described previously [1].
Briefly, the broth medium employed was a dialysate of soy peptone and autoclaved
fresh yeast. It was supplemented with 5 percent dialyzed horse serum, penicillin at
100 units per ml, 1 mM sodium sulfite, and was buffered with 20 mM
2-(N-morpholino)ethane sulfonic acid (MES buffer) at pH 6.3. Filter-sterilized urea
was added at micromolar concentrations indicated in the text. Growth was assessed
by determining colony-forming units (CFU) on MES buffered agar plates [1]. An-
tibiotic sensitivity of U. urealyticum was also determined by incorporating specific
amounts of flurofamide or acetohydroxamic acid into MES agar, inoculating the
plates with organisms, and observing for colonies (an agar dilution test procedure).
A simple color-change method was used for screening concentrations. Medium con-
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FLUROFAMIDE FIG. 1. Structural formulae of urea, acetohydroxamic
N-[diaminophosphinyl]-4-fluorobenzamide acid, and flurofamide.
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taining 5,000 zM urea, 20,000 AM MES buffer, and various concentrations of in-
hibitor was inoculated. An alkaline shift in pH as visualized by phenol red indicator
was a reliable guide to significant growth of U. urealyticum, since the medium was
heavily buffered. For determining flurofamide sensitivities of various mycoplasma
species and Acholeplasma hippikon, agar plates were used which were similar in
composition to MES agar plates but MES buffer was omitted and the pH was ad-
justed to 7.3.
RESULTS
Sensitivity ofU. urealyticum to Flurofamide
Preliminary experiments showed that the growth of U. urealyticum type 8, as evi-
denced by ability to produce an alkaline reaction from phenol red in medium con-
taining 5,000AM urea was inhibited by 10IAM but not by 1 AM flurofamide. In order
to determine whether flurofamide was bacteriocidal or bacteriostatic, growth curves
were conducted using various concentrations of flurofamide and acetohydroxamic
acid (Fig. 2). Flurofamide was a potent inhibitor of growth of U. urealyticum: no
multiplication was observed at either 10 isM or 100 zM in the first eight hours,
whereas control cells without flurofamide grew normally. At both 10 AM and 100
AM flurofamide, viability decreased to the limits of detection by 26 hours. At 1 ptM
flurofamide, the organisms grew well, though other experiments showed clear
evidence of an increased generation time. A concentration of 10,000 AM
acetohydroxamic acid was required to give suppression ofgrowth similar to that ob-
tained with 10 lsM flurofamide. Even so, survival of the organisms was extended to
26 hours. At 1,000 AM acetohydroxamic acid, growth was slower than that of con-
trol cells without inhibitors. Color change was never observed in cultures which
showed no evidence of growth by increase in CFU. Flurofamide appeared to be
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bacteriostatic (ureaplasmastatic), since no evidence of immediate killing was ob-
served in this and other experiments. However, flurofamide was lethal to U.
urealyticum in the sense that the inhibited organisms eventually became non-viable
as evidenced by their inability to form colonies (Fig. 2). The initial inhibition of
growth appeared little different from that obtained by lowering the urea concentra-
tion to 50 AM (Fig. 2), a concentration of urea which gives only survival [1].
Since the above experiment (Fig. 2) showed that the ability of flurofamide to pre-
vent color change of the medium (inhibition of growth of U. urealyticum) was clear
evidence ofinhibition of the organism, a number of strains were tested for inhibition
of growth in broth cultures. Types 1, 2, 3, 4, 5, and 8 were all inhibited by 10AM but
not by ,M flurofamide. When the same organisms were tested by agar dilution,
colonies were visible microscopically on agar plates containing AtM but not 10 AM
flurofamide. Therefore, determination of sensitivity of U. urealyticum to
flurofamide appeared equivalent by the growth-curve, color-change, or agar dilu-
tion methods. A concentration of 10 AM flurofamide (-2 ,ug/ml) appeared suffi-
cient to inhibit the growth of a number of strains of U. urealyticum.
Effect of Urea Concentration on Inhibition by Flurofamide
Since U. urealyticum can grow well in medium containing urea concentrations as
high as 100,000 itM [1], various amounts of urea were added to media containing
none, 1, 10, or 100 AtM flurofamide. These were inoculated with U. urealyticum type
8 and the results assessed by both color change and CFU. Although 10 ,M flurofamide consistently gave inhibition of growth in medium containing up to
10,000 OM urea, growth was not inhibited in media containing 100,000 AM. Both
color change and growth were delayed but significant growth occurred, indicating
that the inhibitory effect of flurofamide was affected by the urea concentration of
the medium. When 100 ptM flurofamide was employed, U. urealyticum did not grow
even in the presence of 100,000 AtM urea.
Effect ofFlurofainide on Other Organisms
Proteus vulgaris grew well in the dialysate broth base without any supplementa-
tion and its growth was not inhibited by 100 AM flurofamide. The agar dilution
method was used to assess inhibition of growth of mycoplasma species and
Acholeplasma hippikon; none were susceptible to 10 AtM flurofamide (see list in
"Materials and Methods"). Mycoplasma hominis grew as rapidly in broth in the
presence of 100 ,uM flurofamide as in its absence, as judged by increase in turbidity.
DISCUSSION
Flurofamide is a powerful inhibitor of growth of U. urealyticum: at 10O M (-2
Aggml), it is as inhibitory as many antibiotics [5]. It is 1,000-fold more active than
acetohydroxamic acid (Fig. 2), a result which correlates exactly with the ratio be-
tween these two compounds as inhibitors of the urease activity of intact Proteus
organisms [7]. My preliminary experiments also show that flurofamide is much
more active as an inhibitor of jack-bean urease. Flurofamide appears to be
bacteriostatic initially, but the organisms eventually die. Apparently, it functions by
depriving the organisms of an essential nutrient, urea. The fact that it is active in
very small quantities and specific to U. urealyticum argues that the hydrolysis of
urea is critical to growth of the organism. Since the inhibition produced by 10 AM
flurofamide can be alleviated by increasing the urea concentration to 100,000 ttM (a
10,000:1 ratio), the inhibition appears specific to urea and likely to urease activity.
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The molecule has a structure similar to the urea molecule (right side of molecule,
Fig. 1) which probably binds in the combining site ofurease. Ifthe fluorine binds to
some amino acid near but not in the combining site, this might stabilize the bond
and explain the great activity of flurofamide. If urease activity is essential to U.
urealyticum, then it may not be possible to obtain a resistant mutant to flurofamide.
However, if a urease-less mutant of U. urealyticum is biologically possible,
flurofamide would prove an excellent tool for its selection. Either result would be of
great interest.
Flurofamide not only has promise as a biochemical tool but it may also be clin-
ically useful as well. It appears reasonably clear that U. urealyticum has a role in
human and animal disease, albeit as an opportunist [9,10]. The fact that flurofamide
is as active as an antibiotic and likely ruthlessly specific to U. urealyticum suggests
that it might be a useful chemotherapeutic agent. Flurofamide has been developed as
a potential agent for the prevention of formation of kidney stones [7]. Apparently,
human trials have not been attempted yet, but they may be in the future.
Flurofamide has an LD50 for mice of2.125 g/kg and possible human dosages ofless
than 5 mg/kg have been suggested for prevention of kidney stones [7]. It is of in-
terest to note that acetohydroxamic acid has been tried in humans for that purpose
[11]. If flurofamide or some similar compound were to be useful in humans, the
probable great specificity of flurofamide would be most useful in specifically
treating ureaplasmic infections and in determining which infections are actually
caused by U. urealyticum. The partial reversal of the inhibitory effect of 10 AM
flurofamide by 100,000AtM urea is ofclinical interest since mammalian blood levels
range from 20,000 to 40,000 zM urea and the concentration of urea in urine reflects
the amount of urea in the blood. Clearly, some in vivo model is needed for further
evaluation of flurofamide and similar compounds. Ifurease or its products are toxic
[12], then flurofamide not only might eliminate the organism but also alleviate im-
mediate toxic reactions. Finally, flurofamide may be important in clinical
microbiology as a selective agent for the elimination of ureaplasmata much as lin-
comycin eliminates large colony forms [5].
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